Ticker: OVID

Ovid Therapeutics Inc. (NASDAQ: OVID) - Quick internal read What's happening inside: management is shrinking costs and pausing at least one program while pursuing strategic alternatives to extend runway. A one‑time Marinus payment boosted Q2 revenue; prior period's large "other income" was a one-...

Ovid Therapeutics Inc. (NASDAQ: OVID) is currently navigating through a complex financial situation as it focuses on the development of pharmacological solutions for brain conditions. Here’s a breakdown of the essential details surrounding their latest financial performance and key developments. ...